SCHEMBL250049

SCHEMBL250049

CN(C)C1(Cc2ccccc2)CCC(NC(=O)CCCC(=O)O)CC1.NC1CCCc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.42
OPRL1 P41146 2/20 0.42
EPHX2 P34913 3/20 0.41
EPHX1 P07099 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
DHODH Q02127 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
DRD2 P14416 2/20 0.38
HTR1A P08908 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4072325 0.86 OPRM1 (0.52) OPRM1OPRL1EPHX2EPHX1
SCHEMBL206079 0.83 OPRM1 (0.54) OPRM1OPRL1EPHX2EPHX1
Phenethylamine SCHEMBL206732 0.81 EPHX2 (0.50) OPRM1OPRL1EPHX2EPHX1
SCHEMBL250598 0.79 OPRM1 (0.43) OPRM1OPRL1EPHX2EPHX1SMN1; SMN2
SCHEMBL207060 0.78 DHODH (0.56) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL209001 0.78 OPRM1 (0.43) OPRM1OPRL1EPHX2EPHX1KMT2A
SCHEMBL2985381 0.78 OPRM1 (0.48) OPRM1OPRL1EPHX2EPHX1
SCHEMBL207196 0.77 OPRM1 (0.46) OPRM1OPRL1EPHX2EPHX1ALDH1A1
SCHEMBL207557 0.76 LMNA (0.52) EPHX1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL208045 0.76 OPRM1 (0.43) OPRM1OPRL1EPHX2EPHX1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed